Blood Group Genotyping for Sickle Cell and Thalassaemia

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Contract ()
Duration
not specified
Value
£141K
Sector
MISCELLANEOUS
Published
05 Dec 2025
Delivery
not specified
Deadline
n/a

Related Terms

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping

Award Detail

1 NHSBT (Bristol)
  • Blood Group Genotyping for Sickle Cell and Thalassaemia
  • Reference: 1
  • Value: £140,671

CPV Codes

  • None found

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

  • ocds-h6vhtk-05f01d
  • FTS 080350-2025

Domains